Delivery Order SPE2DB22D9112-SPE2DB23FE6VU
Award Date 9/8/23
Potential Completion Date 9/29/23
Potential Value $7.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $9,284 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price delivery order, DMS Pharmaceutical will provide 150 mg/ml syringes of Xolair, a medication used to treat allergic asthma and chronic idiopathic urticaria. Performance will take place in Park Ridge, Illinois over a three-week period concluding on September 22, 2023. No...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $46,513.20 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the terms of the award, DMS Pharmaceutical will provide 150 mg/ml syringes of the medication Xolair to support DLA programs. Performance will take place at the contractor's facility in Park Ridge and span from September 29th through October 23rd of this year. No...
- The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, has awarded a $37,137.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under this contract, DMS Pharmaceutical Group will provide 150 mg/ml syringes of the medication Xolair to treat for allergic asthma. The place of performance is listed as the prime contractor's location in Park Ridge. The period of performance is approximately one month, starting...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a $4,642 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the terms of the firm fixed price order, DMS will supply Xolair 150 mg/ml syringes to an DLA facility located in Park Ridge. Performance will take place between September 25 and October 17 of this year. No subcontractors or set aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $1,547 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price contract, DMS Pharmaceutical will provide 150 mg/ml syringes of the medication Xolair, used to treat allergic asthma and chronic idiopathic urticaria. Performance will take place in Park Ridge, running from June 14, 2023 to July 7, 2023. As this delivery order was issued...
- The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at $16,247.70 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for one lot of 150mg/ml Xolair syringes for delivery by September 19, 2023 to the place of performance in Park Ridge. DLA supports military readiness by procuring and providing medical supplies to armed forces personnel. This delivery order for the asthma...
- The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, has awarded a $23,211 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under this order, DMS will provide 150 mg/ml syringes of the medication Xolair to treat for allergic and inflammatory conditions. Performance will take place at DMS's facility in Park Ridge and span from August 3 to August 24, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at approximately $7,737 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under this order, DMS Pharmaceutical will provide 150 mg/ml syringes of the medication Xolair to the DLA. Performance will take place at the contractor's facility in Park Ridge and span from August 31, 2023 through September 22, 2023. No set aside designation or...
- The Defense Logistics Agency Troop Support Medical (DLA) awarded a $4,642 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the terms of the firm fixed price award, DMS will provide 150 mg/ml syringes of Xolair, also known as omalizumab, to support DLA medical programs. Performance will take place in Park Ridge from August 31 to September 22, 2023. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a firm fixed price delivery order valued at approximately $9,284 to DMS Pharmaceutical Group Inc. The order is for Xolair 150 mg/ml syringes to be delivered to a location in Park Ridge, Illinois between September 11, 2023 and October 2, 2023. DMS Pharmaceutical Group will serve as the prime contractor to fulfill this requirement for allergy medication in support of DLA's medical supply chain...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB23FE6VUDelivery Order
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $7,737 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price contract, DMS will provide 150 MG/ML syringes of the medication Xolair to support DLA's medical supply logistics operations. Performance will take place at DMS's Park Ridge facility from September 8th through September 29th of 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA medical product supply vehicle and will enable DLA to maintain critical stockpiles of Xolair, an injectable drug used to treat allergic asthma and other conditions.
Generated 12/22/23, 11:00 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/8/23 |